Nicholas DeMartinis

1.5k total citations
35 papers, 1.1k citations indexed

About

Nicholas DeMartinis is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Nicholas DeMartinis has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 12 papers in Pharmacology and 12 papers in Experimental and Cognitive Psychology. Recurrent topics in Nicholas DeMartinis's work include Treatment of Major Depression (10 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers) and Child and Adolescent Psychosocial and Emotional Development (6 papers). Nicholas DeMartinis is often cited by papers focused on Treatment of Major Depression (10 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers) and Child and Adolescent Psychosocial and Emotional Development (6 papers). Nicholas DeMartinis collaborates with scholars based in United States, Japan and Italy. Nicholas DeMartinis's co-authors include Karl Rickels, Andrew Winokur, Edward E. Schweizer, Laura A. Mandos, Moira A. Rynn, Richard Entsuah, Paul Yeung, Amy Manley, David J. Greenblatt and Irwin Lucki and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Neurology.

In The Last Decade

Nicholas DeMartinis

34 papers receiving 989 citations

Peers

Nicholas DeMartinis

ECP

PHARM

PMH

Peter D. Londborg United States

R. Nil Switzerland

P.M.J. Haffmans Netherlands

Ram Shrivastava United States

Charles S. Wilcox United States

Maurizio Fava United States

Ion Anghelescu Germany

Karl Rickels United States

Ruth Cooper United Kingdom

Ward T. Smith United States

Peter D. Londborg United States

Nicholas DeMartinis

599 ×1.1

ECP

496 ×1.7

PHARM

344 ×1.3

PMH

217 ×0.9

423 ×2.0

Citations per year, relative to Nicholas DeMartinis Nicholas DeMartinis (= 1×) peers Peter D. Londborg

Countries citing papers authored by Nicholas DeMartinis

Since Specialization

Citations

This map shows the geographic impact of Nicholas DeMartinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas DeMartinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas DeMartinis more than expected).

Fields of papers citing papers by Nicholas DeMartinis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas DeMartinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas DeMartinis. The network helps show where Nicholas DeMartinis may publish in the future.

Co-authorship network of co-authors of Nicholas DeMartinis

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas DeMartinis. A scholar is included among the top collaborators of Nicholas DeMartinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas DeMartinis. Nicholas DeMartinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hanson, Elizabeth, Nicholas DeMartinis, Mahnaz Asgharnejad, et al.. (2024). INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia. Schizophrenia Research. 270. 249–257. 15 indexed citations

Xu, Lin, Nicholas DeMartinis, Rohini Sen, et al.. (2021). Results of a randomized double‐blind study evaluating luvadaxistat in adults with Friedreich ataxia. Annals of Clinical and Translational Neurology. 8(6). 1343–1352. 8 indexed citations

Gurrell, Rachel, Sridhar Duvvuri, Pengling Sun, & Nicholas DeMartinis. (2018). A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Dopamine D1 Receptor Partial Agonist, PF-06669571, in Subjects with Idiopathic Parkinson’s Disease. Clinical Drug Investigation. 38(6). 509–517. 14 indexed citations

Naganawa, Mika, Rikki N. Waterhouse, Nabeel Nabulsi, et al.. (2016). First-in-Human Assessment of the Novel PDE2A PET Radiotracer ¹⁸F-PF-05270430. Journal of Nuclear Medicine. 57(9). 1388–1395. 24 indexed citations

Targum, Steven D., et al.. (2014). Impact of BPRS interview length on ratings reliability in a schizophrenia trial. European Neuropsychopharmacology. 25(3). 312–318. 6 indexed citations

DeMartinis, Nicholas, Jayesh Kamath, & Andrew Winokur. (2009). New Approaches for the Treatment of Sleep Disorders. Advances in pharmacology. 57. 187–235. 16 indexed citations

DeMartinis, Nicholas & Andrew Winokur. (2007). Effects of Psychiatric Medications on Sleep and Sleep Disorders. CNS & Neurological Disorders - Drug Targets. 6(1). 17–29. 82 indexed citations

DeMartinis, Nicholas, Paul Yeung, Richard Entsuah, & Amy Manley. (2007). A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Desvenlafaxine Succinate in the Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 68(5). 677–688. 94 indexed citations

Silverman, David I., Nicholas DeMartinis, Kathryn Damato, et al.. (2006). Systematic identification and classification of adverse events in human research. Contemporary Clinical Trials. 27(3). 295–303. 10 indexed citations

10.

Robertson, David, Emily M. Garland, Satish R. Raj, & Nicholas DeMartinis. (2005). Case Report: Marathon runner with severe autonomic failure. The Lancet. 366. S13–S13. 6 indexed citations

11.

Winokur, Andrew, et al.. (2003). Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia. The Journal of Clinical Psychiatry. 64(10). 1224–1229. 103 indexed citations

12.

Liebowitz, Michael R., et al.. (2002). Results from a randomized, double-blind, multicenter trial of sertaline in the treatment of moderate-to-severe social phobia (social anxiety disorder). European Neuropsychopharmacology. 12. 352–352. 1 indexed citations

13.

Furlan, Patricia, Nicholas DeMartinis, Edward E. Schweizer, Karl Rickels, & Irwin Lucki. (2001). Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress. Biological Psychiatry. 50(4). 254–259. 92 indexed citations

14.

Rickels, Karl, Nicholas DeMartinis, Felipe García‐España, et al.. (2000). Imipramine and Buspirone in Treatment of Patients With Generalized Anxiety Disorder Who Are Discontinuing Long-Term Benzodiazepine Therapy. American Journal of Psychiatry. 157(12). 1973–1979. 58 indexed citations

15.

Rickels, Karl, et al.. (2000). A Double-Blind, Placebo-Controlled Trial of Abecarnil and Diazepam in the Treatment of Patients With Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 20(1). 12–18. 40 indexed citations

16.

DeMartinis, Nicholas, Moira A. Rynn, Karl Rickels, & Laura A. Mandos. (2000). Prior Benzodiazepine Use and Buspirone Response in the Treatment of Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 61(2). 91–94. 25 indexed citations

17.

Rickels, Karl, et al.. (1999). Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmacology. 141(1). 1–5. 59 indexed citations

18.

Rickels, Karl, Nicholas DeMartinis, Moira A. Rynn, & Laura A. Mandos. (1999). Pharmacologic Strategies for Discontinuing Benzodiazepine Treatment. Journal of Clinical Psychopharmacology. 19(6 Suppl 2). 12S–16S. 47 indexed citations

19.

Rickels, Karl, Edward E. Schweizer, W G Case, et al.. (1998). Nefazodone in Major Depression. Journal of Clinical Psychopharmacology. 18(2). 145–153. 12 indexed citations

20.

Rickels, Karl, et al.. (1997). Gepirone and Diazepam in Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 17(4). 272–277. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact